FDA: COVID-19 Vaccine Needs To Be Administered As Authorized
Those who who receive the COVID-19 vaccine must get two full doses, the U.S. Federal Drug Administration said amid reports concerning altering how the drug can be administered.
The FDA issued the warning in a statement on Monday, stating it has been following reports about reducing the number of doses, extending the length of time between injections and reducing the size of each dose in order to inoculate more people, warning doing so may "run a significant risk of placing public health at risk."
"These are all reasonable questions to consider and evaluate in clinical trials," Stephen Hahn, commissioner of Food and Drugs at the FDA, and Peter Marks, director of the Center for Biologics Evaluation and Research, said in the joint statement. "However, at this time, suggesting changes to the FDA-authorized dosing or schedules of these vaccines is premature and not rooted solidly in the available evidence."
The two medical experts said they lack appropriate data to support changing how the vaccines were authorized to be administered.
The statement was issued a day after Moncef Slaoui, chief scientific adviser for the Trump administration's Operation Warp Speed vaccine program, told CNN on Sunday that the FDA was considering halving doses of Moderna's COVID-19 vaccine for those between the ages of 18 to 55 to increase the number of people who can be inoculated against the virus.
Hahn and Marks said the public needs to receive the vaccine as it was authorized by the FDA, stating researchers during clinical trials followed those who failed to receive their second shot only for a short period of time so there is not enough data to understand the depth or duration of protection one receives from a single dose of the vaccine.
"If people do not truly know how protective a vaccine is, there is the potential for harm because they may assume that they are fully protected when they are not, and accordingly, alter their behavior to taken unnecessary risks," they said.


Lamont says state on pace to meet vaccine goals
Democrats Call For National Coordinator To Oversee Vaccine Distribution
Advisor News
- Election results cloud retirement legislation outlook, experts say
- Planning for the missing chapter
- Semi-retirement: helping clients balance flexibility with financial security
- The 6X Formula for leveraging content marketing with AI
- When a home becomes difficult to insure, the plan changes
More Advisor NewsAnnuity News
- Jackson Launches Direct-to-Consumer Annuity Offering
- Global Atlantic launches ForeIncome Flex
- Athene CEO criticizes offshore reinsurance, risk-taking by competitors
- DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
- John Hancock launches new fixed indexed annuity suite
More Annuity NewsHealth/Employee Benefits News
- Soaring drug costs squeeze largest Mass. insurer, fueling $43.5M loss
- Health insurers leave Ohio marketplace
- Rising hospital, drug costs boost health insurance premiums at fastest pace since start of Obamacare
- Patients with 3 health insurance plans lose access to Miami health network
- Weld County deputy struggling after being injured by DUI driver (photo gallery)
More Health/Employee Benefits NewsLife Insurance News
- Jackson Launches Direct-to-Consumer Annuity Offering
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on New Zealand’s Non-Life Insurance Segment
- AM Best Affirms Credit Ratings of Fubon Insurance Vietnam Co., Ltd.
- Three lawsuits put life insurers’ cost-of-insurance practices under scrutiny
- Military Briefs: November 12-18
More Life Insurance News